leadf
logo-loader
viewTodos Medical Ltd.

Todos Medical installs automated lab equipment to boost coronavirus testing for Wisconsin client

The installation and scripting of new Tecan EVO200 and Tecan Fluent 780 systems, in combination with the use of Todos’ proprietary ANDis 350 automated RNA extraction systems, significantly boosts the lab’s testing capacity

Swab held next to a bottle labeled 'COVID-19'
Todos also announced that it has secured a proprietary supply chain for the most in-demand lab consumable products required to conduct PCR testing

Todos Medical Ltd (OTCQB:TOMDF) announced Tuesday that it has completed the installation of Tecan laboratory automated equipment at its Wisconsin client’s lab, bringing its total capacity to 12,000 coronavirus (COVID-19) PCR tests per day. 

The installation and scripting of new Tecan EVO200 and Tecan Fluent 780 systems, in combination with the use of Todos’ proprietary ANDis 350 automated RNA extraction systems, significantly boosts the lab’s testing capacity.

The company said it will continue to work with its client to increase testing capacity to 18,000 tests per day in the weeks ahead, and add additional automated liquid handling, extraction and qPCR instrumentation.

READ: Todos Medical says new data from Tollovid study shows its ability to inhibit the 3CL protease, a key element of coronavirus replication

The client primarily services demand from the Wisconsin state government, and, as long as that demand continues to rise, the client said it expects demand for Todos’ testing reagents and consumables to increase to 50,000 COVID-19 PCR tests per day in the next 6 weeks.

Todos also announced that it has secured a proprietary supply chain for the most in-demand lab consumable products required to conduct PCR testing. The supply chain allows the company to source more than 2 million manual and robotic pipette tips per week for its clients, as well as PCR plates. 

An international shortage of lab consumables has emerged as the key limiting step for laboratories to increase their PCR testing capacity, so this supply chain gives Todos a competitive advantage.

“We are excited to have completed this installation process of the Tecan instruments in such a way that we can now replicate this process for several of our clients who are looking to further increase their capacity,” CEO Gerald Commissiong said in a statement. “Now that we have also secured access to sufficient lab consumables to allow our clients to grow unimpeded as compared with their competition, we are becoming laser focused on supporting the further scaling up of our client’s operations within the lab to meet the surging demand for COVID-19 PCR testing in the state of Wisconsin.”

Commissiong said the company has also delivered equipment to a client in Brooklyn.

“Additionally, we have delivered a similar set of equipment, including Tecan liquid handlers, ANDis automated extraction and PCR machines to one of our clients in Brooklyn that will allow it to reach similar COVID-19 testing capacities as our Wisconsin client, and we are working with them to implement the workflow in their lab,” he said. “We expect revenues from our Wisconsin client to increase in the weeks ahead and expect that revenue from our client in Brooklyn to come online in December. We are very excited with the progress we are making in our base PCR lab testing business.”

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: Todos Medical Ltd.

Price: 0.0421 USD

OTCQB:TOMDF
Market: OTCQB
Market Cap: $8.5 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Todos Medical Ltd. named herein, including the promotion by the Company of Todos Medical Ltd. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Todos Medical receives a $3.4 million strategic investment from Yozma Group...

Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive the in vitro diagnostics company has received a $3.4 million strategic investment from tech-focused venture capital firm Yozma Group Korea. Commissiong says Todos intends to use the proceeds from the Investment...

on 01/25/2021

3 min read